Axillary Dissection: No survival advantage seen for older women

LISA SCHULMEISTER, MN, RN, ACNS-BC, OCN, FAAN
Monday, September 22, 2014
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
To address the question of whether axillary dissection is necessary in older women, researchers in Milan, Italy recruited 238 women aged 65-80 years with cT1cN0 breast cancer and randomized them to receive conservative surgery with or without axillary node dissection. The randomized trial started in 1996, and 109 eligible patients who declined to participate in the trial received conservative breast surgery with or without axillary dissection depending on the patient’s preference and/or the surgeon’s opinion. Both the women in the trial and those followed as out-trial patients received conventionally-fractioned whole breast radiation and tamoxifen for five years. Endpoints were breast cancer mortality, overall survival, and cumulative incidence of axillary disease in patients not receiving axillary dissection.

After 15 years of follow-up, breast cancer mortality and overall survival did not differ between the two arms, in either the trial or out-trial groups. The 15-year cumulative incidence of axillary relapse was 6% in women randomized to not receive axillary dissection and none of the women in the out-trial group developed axillary relapse. The researchers concluded that older women with T1N0 breast cancer can be safely and effectively treated with conservative breast surgery, postoperative radiotherapy and tamoxifen for 5 years if ER-positive.


Reference
Martelli G, et al. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients. Eur J Surg Oncol 2014;40(7):805-812.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.